{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-22-001371","form_type":"8-K","ticker":"STEX","cik":"0001530766","company_name":"Streamex Corp.","filed_at":"2022-11-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.041178+00:00","generated_at":"2026-06-21T12:15:47.055290+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BioSig receives Nasdaq delisting notice for failing to meet $2.5M equity requirement","bullets":["Stockholders' equity reported at $1.834M as of Sept 30, 2022, below Nasdaq's $2.5M minimum.","Company also did not meet alternative compliance standards based on market value or net income.","Must submit a compliance plan by January 6, 2023; Nasdaq may grant up to 180-day extension.","No immediate effect on trading of BSGM stock on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-22-001371","json":"https://secwatch.observer/filing/0001185185-22-001371.json","markdown":"https://secwatch.observer/filing/0001185185-22-001371.md","text":"https://secwatch.observer/filing/0001185185-22-001371.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001371/0001185185-22-001371-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001371/biosig20221125_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T12:15:47.055290+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"521d9a489ab5fae3c01cd6065f17c84acdf292a9","claim":"Streamex Corp. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"November 22, 2022, BioSig Technologies, Inc. (the “Company”) received a letter (the “Letter”) from The Nasdaq Stock Market (“Nasdaq”) informing the Company that the Company failed to maintain a minimum of $2,500,000 in stockholders’ equity required for continued listing (the “Stockholders’ Equity Requirement”) on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1) based upon the reported stockholders’ equity of $1,834,000 in the Company’s quarterly report on Form 10-Q for the period ended September 30, 2022 and that as of November 22, 2022, the Company did not meet the alternative c","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522001371/0001185185-22-001371-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}